Expro (NYSE:XPRO) Surprises With Q2 CY2026 Sales

Expro (NYSE:XPRO) reported Q2 CY2026 revenue of $393.2 million, down 7% year on year, but 3% above Wall Street estimates, according to the company. Non-GAAP EPS was $0.15, 16.6% below consensus. Adjusted EBITDA margin was 19.3%, down 3 points. Free cash flow was $50.28 million. Shares were flat at $15.68 after results.

Original reporting
Published Jul 28, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 28, 2026, 12:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Expro (NYSE:XPRO) Surprises With Q2 CY2026 Sales — source image
Decision brief

The 30-second read

$XPRONeutralMed
01

Why it matters

Q2 CY2026 shows a revenue beat but weaker profitability versus consensus, plus commentary that free cash flow is more sensitive to commodity swings than peers. That mix can shift trader focus from top-line growth to margin and cash durability.

02

Market read

Traders get a concrete earnings datapoint set (revenue, EPS, adjusted EBITDA, free cash flow) plus a risk framing (WTI sensitivity) that can influence positioning after the print.

03

What to watch

The article emphasizes cash-flow volatility versus WTI and free-cash-flow margin, but does not quantify guidance or backlog changes, which could be the real driver of the next earnings reaction.

Relevance 6/10Novelty 6/10Timing: after-hours/just after Q2 results, with stock noted flat at $15.68 immediately following

Background

Expro is an oilfield services provider operating across offshore and onshore production, with results framed around cyclicality and cash-generation quality.

Company-level read

Ticker impact

$XPRONeutralMedium confidence
Context

Expro reported Q2 CY2026 revenue of $393.2M, down 7% YoY, but 3% above Wall Street estimates, while non-GAAP EPS missed and adjusted EBITDA fell short.

Expected impact

Choppy trading risk persists after the flat post-results move, with focus shifting to margin and cash-flow durability rather than revenue growth.

Evidence & confidence

The article provides specific datapoints: YoY revenue decline, EPS below consensus, adjusted EBITDA below estimates, and commentary on higher cash-flow sensitivity to WTI. That combination typically limits upside follow-through even when revenue beats.

Market effects

Oilfield services demand appears resilient enough for a revenue beat, but margin and cash-flow sensitivity to crude remain key swing factors for the group.

Middle East conflict is cited as a tempering factor, implying regional disruption risk for activity levels.

WTI-linked cash-flow volatility framing reinforces how global crude moves can transmit into service-provider earnings quality.

Counterpoint

Revenue beat plus sequential improvement from a seasonally weak Q1 could still support a rebound narrative if margins stabilize in subsequent quarters.

Key entities

  • Expro

    Reported Q2 CY2026 revenue, non-GAAP EPS, and adjusted EBITDA versus Wall Street expectations, with commentary on Middle East conflict impacts and cash-flow sensitivity to WTI.

Related articles

$XPROMed

Expro and Noble Corporation Shares Are Soaring, What You Need To Know

Expro (XPRO) and Noble Corporation (NE) shares rose 5.1% and 4% respectively, following a Gulf tanker attack and hurricane-driven production halts, which caused Brent crude to rise above $104 per barrel and WTI to $92. Expro's volatility is noted, with a 19.2% gain year-to-date but still 14.3% below its 52-week high. The company recently secured a multi-year contract, received an analyst upgrade, and plans to move to the Cayman Islands for tax benefits.

$XPROMed

Expro Announces Second Quarter 2026 Results

Expro Ltd (XPRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_983828.htm EXHIBIT 99.1 ex_983828.htm Exhibit 99.1 PRESS RELEASE FOR IMMEDIATE RELEASE Expro Announces Second Quarter 2026 Results HOUSTON - July 28, 2026 – Expro Ltd (NYSE: XPRO) (the “Company” or “Expro”) today reported financial and operational results for the thr

$XPROMedAI 8/10

Expro Completes Enhanced Drilling Acquisition For Approximately $215 Million

Expro said it has completed its acquisition of Enhanced Well Technologies Group AS, or Enhanced Drilling, for about NOK 2 billion (about $215 million) in cash, plus customary adjustments. Expro plans to integrate Enhanced Drilling’s managed pressure drilling and riserless mud recovery services to expand offerings and support earlier well design engagement. Enhanced Drilling operates mainly in offshore markets including the North Sea.

$XPROMed

Expro Completes Acquisition of Enhanced Drilling

Expro Ltd (NYSE: XPRO) said it has closed its acquisition of Enhanced Well Technologies Group AS, or Enhanced Drilling. Expro will pay about NOK 2 billion (about $215 million) in cash, plus customary adjustments. The deal adds managed pressure drilling technologies (MPD, CML, riserless mud recovery) and includes inducement equity awards to 23 employees.

$RDYMed

Dr Reddy's Laboratories Ltd (RDY) (Q2 2027) Earnings Call Highlights: Margin Recovery

Dr. Reddy's Laboratories reported a 1.5% year-over-year revenue decline, driven by lower lenalidomide sales and declines in North America, Europe, and PSAI businesses. The company expects margins to improve with new products and business mix, targeting a 55% gross margin. Semaglutide relaunch is planned for November 2026, and abatacept biosimilar approval is expected by December 2026.